Recurrent mucinous cystadenoma in a 20‐year‐old woman: Was hysterectomy inevitable?

Abstract

A recurrence of ovarian mucinous cysts is very rare. Over a period of 21 months, a 20-year-old patient had three laparotomies resulting initially in the removal of one ovary with a mucinous cystadenoma and two cystectomies for the same pathology, but ultimately leading to hysterectomy and salphingo-oopherectomy. Because mucinous tumors are usually benign and most of the time multilocular, management of young patients is challenging, especially in the case of recurrence. Follow-up of these patients is very important and transvaginal ultrasound seems to be currently the most effective diagnostic tool for the follow-up of young patients treated with cystectomy for benign mucinous cystadenomas.

Imaging in gynecological disease (11): clinical and ultrasound features of mucinous ovarian tumors

“…They are unilateral in 95% of cases. Although benign, recurrence may be seen in cases treated with cystectomy. GI‐type MBOTs occur across a wide age range, from 18–88 years, with a mean age of 40–49 years.…”

Mucinous cystadenoma arising 3 years after ovarian-sparing surgery for mature teratoma in a child

“…The manifestations are typically nonspecific symptoms, such as increasing abdominal girth, abdominal or pelvic pain, emesis, asthenia, constipation, or urinary symptoms. The treatment consists of complete surgical excision, which should be conservative when technically possible [15,17]. Careful follow-up is important because some tumors recur, especially if not completely removed by surgery [16,17].…”

Elevation of Serum CA-125 in Mucinous Cystadenoma of the Ovary with Torsion: A Rare Occurrence and Review of the Literature

“…Less than 20% of ovarian malignancies reportedly arise from ovarian surface epithelial cells [3]. Epithelial tumors of the ovary are rare prior to puberty [4]. The differential diagnosis of ovarian masses in adolescents includes cyst formation, torsion with consecutive edema, benign or malignant ovarian neoplasm, and involvement of the ovary in lymphoma, leukemia, or metastatic disease [5].…”